Skip to main content
. 2020 Jan 8;12(2):e11223. doi: 10.15252/emmm.201911223

Figure EV5. CD13‐AFR/CD13‐AFN‐II combination therapy induces tumor necrosis.

Figure EV5

Representative images of B16Bl6 tumors treated p.l. with 50 μg mCD13‐AFR and/or 23.6 μg mCD13‐AFN‐II, at indicated day after tumor inoculation, are shown. Mice were treated daily from day 10 to day 14.Source data are available online for this figure.